. Regulation of blood pressure, the epithelial sodium channel (ENaC), and other key renal sodium transporters by chronic insulin infusion in rats.
where from 5 to 14 days) has been demonstrated to increase blood pressure modestly in male rats (8, 10, 22, 25, 26, 28) . Upregulation of the sympathetic nervous system (22) , the renin-angiotensin system (8) , thromboxane synthesis (28) , and endothelin-1 (26) has all been implicated as playing a role. Some of the above factors influence vascular tone, which most likely affects blood pressure. However, in addition, many of these factors may influence sodium reabsorption by the kidney. Furthermore, insulin may directly increase sodium reabsorption via receptor-mediated activation of specific renal transport proteins.
In situ binding studies using 125 I-labeled insulin have revealed that insulin receptors are localized along the entire length of the renal tubule, with the density the greatest in the thick ascending limb and distal convoluted tubule (12, 43) . In addition, investigators, utilizing renal micropuncture, have reported that insulin is sodium retentive in the thick ascending limb (30) and/or distal tubule (including thick ascending limb through the collecting duct) (14) . Insulin, when provided in the perfusion bath for isolated, perfused tubule studies, has been shown to increase sodium reabsorption in the proximal tubule (3, 48) , and the thick ascending limb (20, 24, 33, 48) . The ability of insulin to enhance collecting duct sodium reabsorption is less clear. However, A6 cells (toad bladder cells), which are a model for distal tubule cells and express the amiloridesensitive epithelial sodium channel (ENaC), display increased amiloride-sensitive sodium transport in response to insulin (7) . No evidence has been reported for an effect of insulin to stimulate sodium reabsorption in the distal convoluted tubule. However, this is a difficult segment to study and ideal cell lines have yet to be established.
Here, we address the question of whether insulin infusion to induce hyperinsulinemia affects protein abundance, cellular distribution, or activity of specific renal sodium transport proteins and channels of the distal convoluted tubule through the collecting duct. We also determine whether chronic infusion of insulin will result in elevated blood pressure in these same animals. We utilize radiotelemetry to continuously monitor blood pressure over a 4-wk period in response to insulin infusion. We use a novel approach to assess specific sodium channel and transporter subunit activities in vivo by measuring the rats' natriuretic responses to selective sodium transporter and channel blockers. Finally, we utilize immunoblotting and immunoperoxidase labeling to examine the renal abundance and cellular distribution of the following proteins: the thiazidesensitive Na-Cl cotransporter (NCC or TSC) and the ␣-, ␤-, and ␥-subunits of ENaC. We also examine protein abundance of two selected kinases that play important roles in distal tubular sodium reabsorption, i.e., serum-and glucocorticoidregulated kinase-1 (SGK-1), a regulator of ENaC activity (27) , and WNK4 ("with no lysine") kinase, a regulator of NCC activity (53) .
METHODS
Animals, study design, and diets. Eighteen male Sprague-Dawley rats (250 -280 g) were obtained from Taconic Farms (Gaithersburg, MD). After a brief, 3-to 4-day equilibration period, all rats were implanted with radiotelemetric blood pressure transmitters (Data Sciences International, St. Paul, MN). Under isoflurane anesthesia, the pressure-sensitive tip of the fluid-filled catheter of the radio transmitter was advanced into the aorta via an incision in the femoral artery. The body of the radio transmitter was secured into a pouch under the skin near the left hindlimb. Blood pressure was measured for 10 s at 10-min intervals for the entire study. After a 5-to 7-day recovery/ baseline period, rats were randomly assigned to one of the following three treatment groups (n ϭ 6/group): 1) control, 2) insulin-infused, or 3) glucose water-drinking. A second surgery was done at this time to subcutaneously implant osmotic minipumps (Alzet model 2002, Alza, Palo Alto, CA) into insulin-infused rats. Other rats received sham surgery. Human insulin (Humulin-R, Eli Lilly, Indianapolis, IN) diluted with water was infused at a rate of 20 U ⅐ kg body wt Ϫ1 ⅐ day Ϫ1 . The insulin pump was replaced at 2 wk with a new pump in case of insulin degradation. The insulin-infused group and glucose waterdrinking group were given 20% dextrose water to drink in lieu of plain water. The insulin-infused group required this treatment to maintain euglycemia. The glucose water-drinking group was established to control for the high-simple sugar diet of the insulin-infused rats, because consumption of high fructose or glucose has been shown to result in elevated blood pressure and insulin resistance in SpragueDawley rats (23, 40) .
In a preliminary study, insulin-infused rats and glucose waterdrinking rats were found to consume only about half the amount of chow as did the control rats. Therefore, in this study control rats were fed AIN-93G Purified Diet (TD 94045) and insulin-infused and glucose water-drinking rats were fed Purified Diet (2X, TD 04375) ad libitum (Harlan-Teklad, Madison, WI) to better match mineral, fat, protein, and carbohydrate intakes. In this diet, mineral mix, fat, protein, and fiber content were doubled compared with TD 94045. All rats were killed in the fed state. All animals were maintained at all times under conditions and protocols approved by the Georgetown University Animal Care and Use Committee, an American Association for Accreditation of Laboratory Animal Care-approved facility. An additional set of rats was used (control and insulin-treated only, n ϭ 7/group) to confirm natriuretic test results and provide a larger "n" to more comprehensively evaluate immunohistochemistry.
Specific natriuretic tests. After 2 wk, we began a series of tests of natriuresis in response to two select natriuretic agents. The natriuretic response to benzamil (Sigma, St. Louis, MO) was used as an index of relative ENaC activity (17) . This test was performed after 7 days on the study. After a 24-h baseline collection of urine in Nalgene metabolic cages (Harvard Apparatus, Holliston, MA), benzamil (0.7 mg/kg body wt) was administered intraperitoneally (ip) in a single injection based on a previously published therapeutic dose (44) . Urine was then collected in the following time increments after the injection: 0 -3, 3-6, and 6 -24 h. Urinary sodium was measured by an ionselective electrode system (EL-ISE Electrolyte System, Beckman Instruments, Brea, CA). In a second test performed at 14 days, hydrochlorothiazide (HCTZ; 3.75 mg/kg body wt, Sigma) (38) was administered ip and urine was collected as above. The sodium excretory response to HCTZ was used as an index of NCC activity. During the baseline periods, daily food and water intake records were made.
Plasma analyses. Rats were euthanized after 28 days by decapitation, and trunk blood was collected into both heparinized and K ϩ -EDTA-tubes (Vacutainer, Becton-Dickinson, Franklin Lakes, NJ). Heparinized and K ϩ -EDTA blood was centrifuged at 3,000 rpm (Sorvall RT 6000 D, Sorvall, Newtown, CT) at 4°C for 20 min to separate plasma. Plasma aldosterone levels were measured in heparinized plasma using a Coat-A-Count RIA kit (Diagnostic Products, Los Angeles, CA). Insulin was measured in K ϩ -EDTA-containing plasma using an RIA kit (RI-13K, Linco Research, St. Charles, MO). The antibody in this kit cross-reacts with both human and rat insulin. Triglyceride levels were measured in heparinized plasma utilizing an enzymatic colorimetric assay (Sigma).
Preparation of samples for immunoblotting. Both kidneys were rapidly removed. Whole left kidneys and right kidney cortex, inner stripe of outer medulla, and inner medulla were homogenized using a tissue homogenizer (Tissumizer, Tekmar, Cincinnati, OH) in a chilled isolation solution, as previously described (15) . Protein concentrations of the homogenates were measured with a Pierce BCA Protein Assay Reagent Kit (Pierce, Rockford, IL). All samples were then diluted with isolation solution to a protein concentration of between 1 and 3 g/l and solubilized at 60°C for 15 min in Laemmli sample buffer. Samples were stored at Ϫ80°C until ready to be run on gels.
Electrophoresis and blotting of membranes. Initially, Coomassie blue-stained loading gels were prepared for all sample sets to assess the quality of the protein by the sharpness of the bands and to confirm the equality of loading, as previously described (15) . For immunoblotting, 5-30 g of protein from each sample were loaded into individual lanes of precast minigels of 7, 10, or 12% polyacrylamide (Bio-Rad, Hercules, CA). Our immunoblotting protocol and the production, affinity purification, and characterization of the polyclonal antibodies against NCC, ␣-, ␤-, and ␥-ENaC have been previously described (45, 46) . WNK4 was a rabbit anti-human polyclonal antibody obtained from Alpha Diagnostic (San Antonio, TX), and SGK-1 was a sheep polyclonal obtained from Upstate Biotechnology (Lake Placid, NY).
Immunohistochemistry. Separate animals were set up for immunohistochemical examination of the ENaC subunits and NCC. The left kidney was processed in paraffin, and 5-m sections were cut. Heat-induced target retrieval was performed using pH 6 citrate buffer (Zymed Laboratories) to unmask antigenic sites. Endogenous peroxidase activity was stopped by incubation with 2% H 2O2 for 20 min. Tissues were incubated with the primary antibody (1:1,000), i.e., ␣-, ␤-, or ␥-ENaC or NCC, overnight at 4°C. An Envisionϩ System (DakoCytomation, Carpinteria, CA) goat anti-rabbit antibody was used to conduct peroxidase labeling. Then, 3,3Ј-diaminobenzidine tetrachloride dihydrate was applied for 10 min and the tissue was counterstained with Mayer's hematoxylin to allow anatomic definition. A positive reaction was identified as a brown stain in the cytoplasm or a dark brown/black nuclear stain as a result of superimposition of the 3,3Ј-diaminobenzidine tetrachloride dihydrate reaction and the blue counterstain. Pictures were taken with a Photometrics Cool Snap camera (Scanalytics, Fairfax, VA) mounted to a Nikon Eclipse E600 microscope with a ϫ100 oil-immersion lens for a total magnification of ϫ1,000.
Statistics. Data were evaluated by SigmaStat (Chicago, IL). Oneway ANOVA followed by Tukey's multiple comparisons test was used to determine significant differences between means.
RESULTS

Physiological effects of insulin infusion.
There were no significant differences in measured sodium intake and total measured calories consumed per body weight or in final body weight due to treatment, although there was a trend for insulininfused rats to be heavier (Table 1 ). In fact, there was a significant increase in weight gain in the insulin-infused rats. Interestingly, kidney weight normalized to body weight was significantly lower in the insulin-infused and glucose-drinking rats. Finally, blood glucose levels measured at the end of the study were not different between the treatments.
Plasma components. Sodium and potassium concentrations in the plasma were not significantly different due to treatment ( Table 2) . As expected, plasma insulin was increased by insulin infusion. Aldosterone and renin activity was not affected by treatment. There were no significant differences in triglyceride concentrations between groups.
Blood pressure changes. In a preliminary study in which rats were fed equivalent diets and sodium intake was reduced by ϳ50% in insulin-infused and glucose-drinking rats (see METH-ODS), we observed no differences between treatments for mean arterial blood pressure (MAP). However, in this study MAP was significantly elevated in the both the glucose waterdrinking group and the insulin-infused group, relative to control rats, after 16 or 20 days, respectively (Fig. 1) . The increase was between 5 and 10 mmHg. There were no differences between the glucose-drinking and the insulin-infused groups, however, at any time point.
Response to selective natriuretic agents. Sodium excretion in response to a single administration of selective natriuretic agents was used as a novel test of specific transporter or channel activities. Responses to benzamil and HCTZ are shown in Fig. 2, A and B, respectively. We plotted data as absolute sodium excretion because baseline urinary excretion for sodium was not different. The natriuretic response to both agents was observed in the first 3-h urine collection. The insulin-infused rats excreted 125 and 60% more sodium in response to benzamil and HCTZ, respectively (a significant increase), relative to control rats, possibly indicating greater in vivo activity of ENaC and NCC. These tests were repeated in a separate set of animals for the insulin-infused and control Values are means Ϯ SE; n ϭ 6/group for all comparisons. Sodium, water/fluid, dry food, and kcal intakes are averages of measurements made at 6, 13, and 20 days. BW, body wt. *Significantly (P Ͻ 0.05) different from the control mean, as determined by 1-way ANOVA followed by Tukey's multiple comparisons test. Values are means Ϯ SE; n ϭ 6/group for all comparisons. Renin activity is expressed as generated angiotensin I. *Significantly (P Ͻ 0.05) different from the control mean and †from the glucose-drinking mean, as determined by 1-way ANOVA followed by Tukey's multiple comparisons test. Fig. 1 . Average mean arterial blood pressures (MAP) plotted every 4 days (n ϭ 6/treatment/time point). MAP was significantly increased in glucosedrinking and insulin-infused rats relative to control rats after 16 or 20 days, respectively. *Significantly different (P Ͻ 0.05) from control by 1-way ANOVA followed by Tukey's multiple comparisons test. Fig. 2 . Responses to selective natriuretic agents (n ϭ 6/group/time point). Sodium excretion in the various timed collections in response to benzamil (A) and hydrochlorothiazide (B; expressed as absolute sodium excretion) is shown. Insulin-infused rats had a significantly greater response to both benzamil and thiazide in the first 3-h collections. *Significantly different (P Ͻ 0.05) from control by 1-way ANOVA followed by Tukey's multiple comparisons test. treatments (n ϭ 7/group). In this case, we confirmed an increase in sodium excretory response in the insulin-infused rats relative to the control rats in response to both benzamil and HCTZ. Insulin-infused rats excreted 145 and 76% more sodium in response to HCTZ and benzamil, respectively, than did control rats (P Ͻ 0.012).
ENaC subunits. In Fig. 3 , we show representative immunoblots from the whole kidney, cortex, outer, and inner medullary homogenates probed with anti-␣-, ␤-, or ␥-ENaC antibodies. A summary of densitometric statistics are found in Tables 3 (␣- and ␤-ENaC) and 4 (␥-ENaC). An equal amount of total protein (20 -30 g) was loaded in each lane of each blot. In the cortex and whole kidney homogenates, there were no significant differences between any of the groups for the densities of any of the ENaC channel subunit bands. However, in the inner medulla, ␤-ENaC was modestly but significantly decreased in the insulin-infused rats relative to the glucose water-drinking rats; and in the outer and inner medulla, the lower (70-kDa band) associated with ␥-ENaC was increased in the glucose water-drinking rats relative to control.
ENaC immunohistochemistry. Because we found an increase in natriuretic activity in response to benzamil, yet very little change in ENaC subunit protein abundances, we elected to examine subcellular localization of the subunits, because trafficking to the apical membrane, most likely to increase activity, has been demonstrated (32, 34) . Representative immunoperoxidase labeling of ␣-ENaC in the cortex (top), outer medulla (middle), and inner medulla (bottom) is shown in Fig. 4 . Labeling for ␣-ENaC was fairly intense in the collecting duct principal cells of the cortex and outer medulla in all treatments. However, lesser labeling was observed in the inner medullary collecting ducts. Staining for ␣-ENaC was more apical in the rats treated with insulin, especially in the cortex (top, middle column), whereas the staining appeared more diffuse in the control rats (top, left column).
In Fig. 5 , we show immunoperoxidase labeling for ␤-ENaC. Like ␣-ENaC, ␤-ENaC labeling appeared most intense near the apical membrane of the principal cells in the cortex in insulininfused rats. Lesser labeling was observed in the outer medullary collecting duct for all treatments.
Representative immunoperoxidase-labeling of ␥-ENaC is shown in Fig. 6 . ␥-ENaC labeling was found in all regions, and the stain was most intense in the apical membrane of insulininfused and glucose-drinking rats. Again, the labeling pattern was more diffuse in control rats.
NCC. In Fig. 7 , representative immunoblots probed with our NCC antibody loaded with whole kidney or cortex homogenates (A and C) and bar graph summaries (B and D) are shown. NCC abundance was not significantly affected by treatment. Fig. 3 . Representative immunoblots for the amiloride-sensitive epithelial sodium channel (ENaC) subunits ␣-ENaC (A), ␤-ENaC (B), and ␥-ENaC (C) in whole kidney, cortex, outer medulla, and inner medullary homogenates, respectively (top to bottom). Each lane was loaded with an equal amount of total protein from a different rat's sample (n ϭ 6/treatment). Blots were probed with one of our own specific antibodies against the ENaC subunits (45, 46). Significantly different mean band density (P Ͻ 0.05) from control (*) and glucose-drinking group () by 1-way ANOVA followed by Tukey's multiple comparisons test. Values are means Ϯ SE; n ϭ 6/group for all comparisons. ENaC, epithelial sodium channel. *Significantly (P Ͻ 0.05) different from the glucose-drinking mean, for that protein, as determined by 1-way ANOVA followed by Tukey's multiple comparisons test. Figure 8 shows representative immunoperoxidase labeling in a control rat, an insulin-infused rat, and a glucose water-drinking rat. We saw exclusive labeling of the apical portion of the distal convoluted tubule cells in all treatments. No discernible differences in expression level or cellular distribution were found.
WNK4 and SGK-1. Finally, to more comprehensively address the mechanism underlying the observed greater response to the ENaC-and NCC-selective natriuretic agents in the insulin-infused rats, we elected to look at the protein abundances of two regulatory proteins, i.e., SGK-1, shown to regulate ENaC trafficking (27) , and WNK4 kinase, shown to reduce NCC activity (53) . In Fig. 9A , we show sample immunoblots for SGK-1. Clearly, no significant differences were found for this protein. WNK4 is shown in Fig. 9B . The specific band for this protein runs at ϳ155 kDa (51). We found a modest but significant decrease in this band in cortex homogenates in the insulin-infused rats relative to controls (P Ͻ 0.05). The same trend was seen in whole kidney homogenates; however, the difference was not significant (P ϭ 0.076).
DISCUSSION
In the present study, we have demonstrated that long-term infusion of insulin causes a modest but significant increase in MAP in male Sprague-Dawley rats. In general, this study is in agreement with several others (10, 16, 25, 35, 49) showing an increase in MAP in rats infused with insulin. However, unlike others, we used continuous radiotelemetry to record blood pressure, whereas most others used tail-cuff recording or direct intra-arterial readings by an externalized in-dwelling catheter. Additional stimulation of the sympathetic nervous system due to stress surrounding tail-cuff recording or tethering using the externalized catheter method might have affected the outcome in some of the other studies (likely to exacerbate responses), especially during hyperinsulinemia, a model that has been demonstrated to have elevated sympathetic activity associated with it (1, 22, 37, 42) . Therefore, our animal model is unique in that we were able to probe the role of sodium transporters in vivo in a chronically instrumented rat in which MAP has been measured continuously over the length of the study.
Also, in agreement with others (23, 40) we showed that the consumption by rats of a diet high in a simple sugar, i.e., Fig. 4 . Immunoperoxidase labeling of ␣-ENaC. ␣-ENaC was localized on tissue with our own specific antibody against the ␣-ENaC subunit (45, 46) . Shown are examples of staining in collecting duct principal cells in (top to bottom) cortex (CTX), outer medulla (OM), and inner medulla (IM; ϫ1,000 magnification) from a control (left), insulin-infused (middle), and glucose-drinking rat (right). ␣-ENaC is expressed in collecting ducts of the cortex and outer medulla in all treatments, and lesser labeling was observed in the inner medullary collecting ducts, especially in control rats. ␣-ENaC appeared more apically localized in the cortex of insulin-infused rats.
glucose in the drinking water, also raises blood pressure, in our case, to a similar degree as the insulin infusion. This is likely due to the development of insulin resistance in these rats (4, 18, 23) . We did not plan to address the degree of insulin resistance in this study. Nevertheless, it is important to consider the possibility that the hypertension caused by the insulin infusion may have also been due to the development of insulin resistance rather than to a direct response to the insulin. Insulin has been demonstrated to increase Ca 2ϩ -ATPase activity (54) and endothelial nitric oxide release (47) from endothelial tissue, thus resulting in vasodilation in sensitive tissues, phenomena expected to lower, not raise, blood pressure. In line with this, Hall and associates (11, 21) have consistently demonstrated that dogs, which do not as readily develop insulin resistance when infused with physiological levels of insulin, fail to show an increase in blood pressure, even in the presence of reduced kidney mass and high sodium intake, which should render the animal highly susceptible to hypertensive stimuli.
These data in combination with our preliminary work also suggest that the increase in blood pressure observed with insulin infusion was "salt sensitive," because no differences in blood pressure were observed between groups when dietary sodium intake of the insulin-infused and glucose-drinking rats was only half that of the control group (see RESULTS, Blood pressure changes). This was contrary to Brands et al. (9) , who showed no differences in the rise in MAP in rats given anywhere from 0.6 to 11.4 meq Na ϩ /day while being infused intravenously for 7 days with ϳ2.5 U insulin⅐kg body wt Ϫ1 ⅐day
Ϫ1
. However, it is in agreement with Tomiyami et al. (49) , who showed increased MAP with insulin infusion in salt-sensitive, but not salt-resistant, Dahl rats, and only when they were fed a high-salt diet. Differences in study length, achieved plasma insulin levels, blood glucose levels, and other unknown variables may have resulted in these different findings.
Despite similarly increased MAP between insulin-infused and glucose-drinking rats, only rats receiving the insulin infusion had an increased natriuretic response to benzamil (a selective ENaC inhibitor) and HCTZ (a selective Na-Cl cotransporter inhibitor). This may imply that the mechanisms underlying the increase in blood pressure between these two treatments are different. Perhaps insulin infusion increases distal tubule sodium reabsorption associated with it and glucose drinking does not. A variation of this approach, termed "pharmacological blockade or knockout" of sodium channel or transporter activity, was employed by Frindt et al. (19) using Fig. 5 . Immunoperoxidase labeling of ␤-ENaC. ␤-ENaC was localized on tissue with our own specific antibody against the ␤-ENaC subunit (45, 46) . Shown are examples of staining in the (top to bottom) cortical, outer medullary, and inner medullary collecting ducts (ϫ1,000 magnification) from a control (left), insulin-infused (middle), and glucose-drinking rat (right). Labeling was most intense in the apical cell membranes in the cortex of insulin-infused rats.
amiloride (rather than benzamil) to block ENaC and polythiazide to block NCC. In those studies, the drugs were given to assess the contribution of ENaC vs. NCC reabsorption of sodium in rats that were on a sodium-deprived diet. However, the use of such agents to gauge the activity of these specific transport routes is quite novel and thus may be subject to skepticism. The fact that the natriuretic response to each of these agents was positive (relative to baseline), different (between the treatment groups), appropriate to expectations (with regard to degree of response), and reproducible among different groups of rats indicates that pharmacological blockade may be a valuable means of identifying sites of altered transport in Fig. 6 . Immunoperoxidase labeling of ␥-ENaC. Shown are examples of staining in the (top to bottom) cortical, outer medullary, and inner medullary collecting ducts (ϫ1,000 magnification) from a control (left), insulin-infused (middle), and glucose-drinking rat (right). ␥-ENaC labeling was found in all regions, with increased apical residency in the cortex of insulin-infused and glucose-drinking rats. Fig. 7 . Thiazide-sensitive Na-Cl cotransporter (NCC) immunoblotting and bar graph summary. Representative blots and bar graph of whole kidney (A and B) and cortex homogenates (C and D) are shown. Each lane was loaded with an equal amount of total protein from a different rat's sample (n ϭ 6/treatment). Blots were probed with our own anti-NCC antibody (45, 46) . No significant differences were observed between treatments for band density. the kidney. Nevertheless, it is important to also consider the possibility that differences in volume status, rate of drug absorption from the intraperitoneal cavity, and/or distribution throughout the body might exist between treatments and thus might also affect the response.
Insulin has been shown to increase sodium reabsorption through ENaC in A6 cells and cortical collecting duct cell lines via activation, likely phosphorylation, of SGK-1 (7, 39, 41, 50) . However, whether insulin may also change the protein abundances of individual subunits of ENaC, as do aldosterone (34) and vasopressin (15) , is not known. In this study, when sodium levels were matched, we found that a chronic yet modest (ϳ2ϫ) elevation in circulating levels of insulin did not dramatically affect the protein abundances of any of the subunits, nor did it affect the ratio of the 70-to 85-kDa band of ␥-ENaC as does aldosterone (34) . Furthermore, NCC abundance, also shown to be increased by aldosterone (29) , was not significantly increased by insulin infusion or glucose drinking in this study.
On the other hand, we did see increased apical residency of ␣-, ␤-, and ␥-ENaC in the cortical collecting ducts from the insulin-infused rats relative to control. This occurred despite no measurable change in the final circulating level of plasma aldosterone in these rats (Table 2 ). Aldosterone has also been shown to increase apical residency of ENaC (32, 34) . Therefore, the increase in ENaC on the apical membrane may have been the cause of the increased benzamil responsivity in these rats. In addition, it might have played a role in the elevated blood pressure; however, an absolute causal relationship between these variables could not be determined from this study.
However, inappropriately high ENaC or NCC activity has been associated with hypertension in humans with Liddle's or Gordon's syndrome, respectively (31, 51) .
In addition, WNK4 kinase has been shown to inhibit NCC by phosphorylating the transporter (52) . It may also suppress its delivery to the plasma membrane (53) . We found a significant decrease in the density in WNK4 on the immunoblot for the insulin-infused rats relative to the glucose water-drinking rats. This may explain the differential response of these two groups to HCTZ. However, we did not find clear discernible differences in cellular distribution of NCC with immunoperoxidase-based labeling.
Furthermore, it is possible that if we had achieved a relatively higher level of circulating insulin via the infusion, we might have observed a significant effect on ENaC and NCC abundances. However, this study would necessitate coinfusion of glucose to control hypoglycemia. Based on our preliminary work, this is difficult to titrate, stressful to the animals in a chronic scenario, and results in weight loss in the animals. Unlike aldosterone or vasopressin, which we can manipulate over fairly high ranges in the circulation to study their physiological roles in renal transport, high levels of insulin, in an insulin-sensitive rat can rapidly lead to hypoglycemia and death.
On the other hand, insulin-resistant rat models such as the obese Zucker rat have 2-to 10-fold higher circulating levels of insulin (5, 6) . In these animals, we found an increase in the abundance of the ␤-subunit of ENaC as well as NCC. However, additional studies will need to be done to determine Fig. 8 . Immunoperoxidase labeling of NCC. NCC was localized on tissue with our own specific antibody against NCC (45, 46) . Shown are examples of staining in the distal convoluted tubule (ϫ1,000 magnification) from a control (left), insulin-infused (middle), and glucose-drinking rat (right). Labeling was very strong and apically localized to the distal convoluted tubules in all three treatments. No clear differences were discernible. Fig. 9 . Serum-and glucocorticoid-regulated kinase-1 (SGK-1) and "with no lysine" kinase (WNK4) immunoblots. Shown are representative blots for SGK-1 (A) and WNK4 (B) of whole kidney (top) and cortex (bottom) homogenates, respectively. Each lane was loaded with an equal amount of total protein from a different rat's sample (n ϭ 6/treatment). Blots were probed with either a sheep polyclonal antibody against SGK-1 (Upstate Biotechnology; A) or a rabbit polyclonal antibody against WNK4 (Novus Biologicals; B). *Mean band density is significantly different (P Ͻ 0.05) from that of the control group by 1-way ANOVA followed by Tukey's multiple comparisons test.
whether the insulin receptors in the kidney become "resistant" as do peripheral insulin receptors in these rats.
Overall, chronic insulin infusion as well as drinking of a glucose solution were shown to increase blood pressure in rats when dietary sodium intakes were carefully matched. This increase corresponded to, and thus may have been the result of, increased activity of distal renal tubular sodium transport pathways including NCC and ENaC, possibly via trafficking into the apical membrane.
